Kihara H, Fluharty A L, Ng W G, Leider W
J Inherit Metab Dis. 1982;5(4):215-7. doi: 10.1007/BF02179145.
Diagnosis of metachromatic leukodystrophy (MLD) was established in the proband at age 27 months. An examination of the family arylsulphatase A profile revealed that the father and younger sibling, age 2 months, had very low enzyme activities like the proband. The father, in all likelihood, had the pseudo arylsulphatase A deficiency trait, but the sibling could be either pseudodeficient or affected with MLD. The fibroblast cerebroside sulphate loading test confirmed that the father had pseudo arylsulphatase A deficiency. The test also indicated that the sibling was affected with MLD. This was confirmed by clinical evidence of neurological degeneration by 18 months.
先证者在27个月大时被确诊为异染性脑白质营养不良(MLD)。对家族芳基硫酸酯酶A谱的检查显示,父亲和2个月大的弟弟,酶活性与先证者一样非常低。父亲很可能具有假性芳基硫酸酯酶A缺乏特征,但弟弟可能是假性缺乏或患有MLD。成纤维细胞脑苷脂硫酸盐负荷试验证实父亲患有假性芳基硫酸酯酶A缺乏症。该试验还表明弟弟患有MLD。18个月时神经退行性变的临床证据证实了这一点。